By activating substrates such as TGF-β [28], MMPs and integrins [50], furin can enhance extracellular matrix degradation, epithelial–mesenchymal transition, and stromal activation, thereby supporting tumor progression. The gene discussed is FURIN; the disease is neoplasm.